White matter necrosis (WMN) constitutes a dose-limiting toxicity of combined radiation and chemotherapy treatment of CNS neoplasms. Unfortunately, the pathophysiology of WMN is not known, hampering prediction, prevention and treatment. This research proposal will test the hypothesis that WMN results from the intramitotic death of glial cells in the cervical spinal cord or glial precursors in the subependymal plate (SEP), caused by chemotherapy (CT), radiotherapy (RT) or a combination of both modalities. This overall hypothesis will be evaluated by testing six specific hypothesis in the juvenile rat: 1) Proliferating cells of the SEP in the 9-day-old rat give rise to cells which migrate to the subcortical white matter. Ablation of these cells results in WMN; 2) Whole brain RT in the juvenile rat results in sequential, dose-dependent alteration in the cell density of the SEP and subsequent dose-dependent white matter change, including WMN; 3) Single bolus administration of MTX or thioTEPA results in dose-dependent alteration of SEP cell density. Serial administration results in persistent, dose-dependent decline in SEP cell density and subsequent dose-dependent white matter change, including WMN; 4) Combined treatment with RT and CT results in an additive loss of cells in the SEP; 5) When administered continuously during the latent period prior to the onset of WMN following cervical cord RT, MTX increases the incidence of WMN; 6) RT of the cervical cord and prolonged intraventricular administration of MTX each results in sequential and dose-dependent depletion of the cervical cord glial cell population. When both are administered, the decrease in glial cell number is additive. These hypotheses will be tested by examining glial or SEP cell depletion and incidence of WMN in animals treated at nine days of age with CT, RT or both modalities. An understanding of the pathophysiology of WMN will allow pre-clinical testing of proposed antineoplastic agents for chronic neurotoxicity, either when used alone or in combination with RT and may allow rational scheduling of antineoplastic treatment to minimize the possibility of this adverse outcome. Finally, radio-chemoprotection might be possible if the target cell population is known.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA001451-02
Application #
3079937
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Project Start
1989-08-02
Project End
1994-07-31
Budget Start
1990-08-01
Budget End
1991-07-31
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Robertson, P L; Zeltzer, P M; Boyett, J M et al. (1998) Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 88:695-703
Geyer, J R; Finlay, J L; Boyett, J M et al. (1995) Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group. Cancer 75:1045-50
Geyer, J R; Zeltzer, P M; Boyett, J M et al. (1994) Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol 12:1607-15
Seaver, E; Geyer, R; Sulzbacher, S et al. (1994) Psychosocial adjustment in long-term survivors of childhood medulloblastoma and ependymoma treated with craniospinal irradiation. Pediatr Neurosurg 20:248-53
Bourne, J P; Geyer, R; Berger, M et al. (1992) The prognostic significance of postoperative residual contrast enhancement on CT scan in pediatric patients with medulloblastoma. J Neurooncol 14:263-70
Geyer, J R; Schofield, D; Berger, M et al. (1992) Differentiation of a primitive neuroectodermal tumor into a benign ganglioglioma. J Neurooncol 14:237-41
Geyer, J R (1992) Infant brain tumors. Neurosurg Clin N Am 3:781-9
Geyer, R; Levy, M; Berger, M S et al. (1991) Infants with medulloblastoma: a single institution review of survival. Neurosurgery 29:707-10;discussion 710-1